Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 1
2019 6
2020 2
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer.
Vathiotis IA, MacNeil T, Zugazagoitia J, Syrigos KN, Aung TN, Gruver AM, Vaillancourt P, Hughes I, Hinton S, Driscoll K, Rimm DL. Vathiotis IA, et al. Among authors: aung tn. Cancers (Basel). 2021 Mar 1;13(5):1024. doi: 10.3390/cancers13051024. Cancers (Basel). 2021. PMID: 33804482 Free PMC article.
An effective drug sensitizing agent increases gefitinib treatment by down regulating PI3K/Akt/mTOR pathway and up regulating autophagy in non-small cell lung cancer.
Zhang J, Qu Z, Yao H, Sun L, Harata-Lee Y, Cui J, Aung TN, Liu X, You R, Wang W, Hai L, Adelson DL, Lin L. Zhang J, et al. Among authors: aung tn. Biomed Pharmacother. 2019 Oct;118:109169. doi: 10.1016/j.biopha.2019.109169. Epub 2019 Jul 13. Biomed Pharmacother. 2019. PMID: 31310954 Free article.
18 results